Normocain (Articaine Hydrochloride, Epinephrine)

Articaine hydrochloride, the active ingredient in Normocain, is a local anesthetic (amide type) presented as a dental infiltration solution for infiltration and perineural (nerve block) use. It provides reversible inhibition of nerve impulse transmission, allowing pain control during dental procedures in adult patients.

GNH USA supplies Normocain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory documentation for cross‑border distribution. Customers benefit from reliable logistics, temperature‑controlled shipping where required, and responsive technical support.

Normocain, an amide‑type local anesthetic, is used in dental practice to achieve reversible loss of sensation. - Dental infiltration: provides rapid onset anesthesia for routine restorative procedures. - Nerve block (inferior alveolar, mental, etc.): enables profound anesthesia for extractions and surgical interventions. - Periodontal surgery: facilitates pain‑free manipulation of gingival tissues during flap procedures.

Adverse reactions to Normocain are generally related to the local anesthetic component or the vasoconstrictor.

Common Side Effects: - Tingling, numbness, or a pins‑and‑needles sensation localized to the injection area. - Mild to moderate headache occurring shortly after administration. - Transient dizziness or light‑headedness that resolves without intervention.

Serious or Rare Side Effects: - Allergic response presenting as rash, itching, urticaria, or, in severe cases, anaphylaxis. - Significant hypotension or cardiac arrhythmia, especially in patients sensitive to epinephrine. - Persistent paresthesia, nerve injury, or rare methemoglobinemia requiring medical evaluation.

When using Normocain, clinicians should observe specific precautions to minimize adverse events and ensure optimal efficacy. - Patient assessment: verify medical history for cardiovascular disease, hypertension, or arrhythmias before administration. - Allergy check: confirm no known hypersensitivity to amide local anesthetics or epinephrine. - Dosage limitation: adhere to maximum recommended dose based on patient weight and site of injection. - Epinephrine caution: avoid use in patients taking non‑selective beta‑blockers or with hyperthyroidism. - Monitoring: observe the patient for signs of systemic toxicity during and after the procedure. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Normocain may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective beta‑blockers: may potentiate epinephrine‑induced hypertension and tachycardia. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis when combined with epinephrine. - Tricyclic antidepressants: can lower seizure threshold, heightening risk of CNS toxicity.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): may increase bleeding tendency at injection sites. - Sympathomimetic drugs (e.g., pseudoephedrine): can augment cardiovascular effects of epinephrine. - Diuretics: may enhance systemic absorption of the anesthetic, requiring observation.